Rabeprazole Sodium Patent Expiration
Rabeprazole Sodium is Used for treating peptic ulcers. It was first introduced by Waylis Therapeutics Llc
Rabeprazole Sodium Patents
Given below is the list of patents protecting Rabeprazole Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aciphex |
US5045552 (Pediatric) | Pyridine derivatives having anti-ulcerative activity |
Nov 08, 2013
(Expired) | Waylis Therap |
| Aciphex Sprinkle |
US5045552 (Pediatric) | Pyridine derivatives having anti-ulcerative activity |
Nov 08, 2013
(Expired) | Aytu |
| Aciphex | US5045552 | Pyridine derivatives having anti-ulcerative activity |
May 08, 2013
(Expired) | Waylis Therap |
| Aciphex Sprinkle | US5045552 | Pyridine derivatives having anti-ulcerative activity |
May 08, 2013
(Expired) | Aytu |
Rabeprazole Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List